Patent · US Active

NLRR-1 antagonists and uses thereof

US8691222B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignee

Genentech, Inc. · US

Inventors

Meredith Hazen · South San Francisco, US
Jo-Anne Hongo · Redwood City, US
Victoria Smith · Burlingame, US
Susanna Y. Stinson · Belmont, US

Key dates

Filing date	Oct 1, 2008
Grant date	Apr 8, 2014
Priority date	—
Expiry date	Feb 16, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

NLRR-1 antagonists and methods of their use in treating cancer and other disorders are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.